Cryo-Cell International, Inc. CCEL
AMEX
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.95M | -2.47M | -2.67M | -2.43M | -473.50K |
| Total Depreciation and Amortization | 1.35M | 1.37M | 1.37M | 1.37M | 1.38M |
| Total Amortization of Deferred Charges | 20.50K | 20.60K | 20.70K | 20.80K | 20.90K |
| Total Other Non-Cash Items | 3.21M | 3.44M | 3.69M | 3.68M | 1.98M |
| Change in Net Operating Assets | 2.28M | 3.95M | 2.76M | 2.84M | 3.45M |
| Cash from Operations | 4.92M | 6.32M | 5.18M | 5.48M | 6.35M |
| Capital Expenditure | -268.90K | -205.80K | -235.50K | -230.50K | -171.60K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 115.00K | 115.00K | 115.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -147.40K | 1.07M | -548.20K | -859.80K | -1.74M |
| Cash from Investing | -416.30K | 869.10K | -668.70K | -975.30K | -1.80M |
| Total Debt Issued | 3.20M | 3.20M | 7.20M | 8.80M | 8.82M |
| Total Debt Repaid | -6.57M | -9.98M | -10.32M | -10.17M | -7.98M |
| Issuance of Common Stock | 23.30K | 46.40K | 23.10K | 23.10K | 98.50K |
| Repurchase of Common Stock | 0.00 | -80.90K | -169.50K | -169.50K | -169.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | 0.00 | -1.21M | -3.23M | -5.25M |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | -3.34M | -6.81M | -4.48M | -4.75M | -4.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.16M | 369.70K | 26.50K | -241.90K | 67.80K |